NervGen Pharma's total assets for Q2 2026 were C$90.34M, an increase of 289.23% from the previous quarter. DE:9UA total liabilities were C$73.03M for the fiscal quarter, a 270.11% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.